Peptide record

TPDB42770

oligopeptide 3 Anticancer standard
4 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB42770
oligopeptide 3
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 4-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
RDTQ
Physicochemical Analysis
C19H34N8O9
ANCEGHILKMFPSWYV
RDQT
518.53
6.78
1
1
0
-0
2.76
-3.050
0.00
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
0
0.00
2
Residue Composition
number
0
A
1
R
0
N
1
D
0
C
0
E
1
Q
0
G
0
H
0
I
0
L
0
K
0
M
0
F
0
P
0
S
1
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 1 N: 0 D: 1 C: 0 E: 0 Q: 1 G: 0 H: 0 I: 0 L: 0 K: 0 M: 0 F: 0 P: 0 S: 0 T: 1 W: 0 Y: 0 V: 0
Chemical Descriptors
4
C19H34N8O9
518.53
6.78
-0
2.76
-3.050
Free
L
Linear
Free
Anticancer
Sarcophyton glaucum
Evidence Records 1 records
Evidence 1 Activity

Activity

EC50
EC50 = 5.6 mmol/L
Anticancer
5.6 mm

Target

Cervical Cancer
HeLa
Cervix

Assay & Model

MTT assay
26 h

Source & Reference

CancerPPD 2.0
CancerPPD2
2019

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.